Revenue for the health system increased 11% year over year to $6.9 billion while expenses rose 9% to $6.8 billion, according to financial documents published Feb. 28. Labor costs increased 6% to $3.5 billion and supply costs jumped 15% to $2.9 billion.
After accounting for nonoperating items, including $560.9 million in investment returns, BJC ended 2023 with a net profit of $736.5 million, compared to a loss of $170.3 million the previous year.
Net assets at the end of 2023 totaled $8.6 billion, compared to $8 billion in 2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
